Cargando...
Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy
BACKGROUND: To evaluate the transmembrane clearance (CL(TM)) of apixaban during modeled in vitro continuous renal replacement therapy (CRRT), assess protein binding and circuit adsorption, and provide initial dosing recommendations. METHODS: Apixaban was added to the CRRT circuit and serial pre-filt...
Guardado en:
| Publicado en: | BMC Nephrol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7847018/ https://ncbi.nlm.nih.gov/pubmed/33516188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-021-02248-7 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|